查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生物标记发现外包服务市场，按类型，按治疗区域，通过发现阶段，最终使用，按国家和地区 - 工业分析，市场规模，市场份额，市场份额和预测从2023-2030开始
市场调查报告书
商品编码
1388778

生物标记发现外包服务市场，按类型，按治疗区域，通过发现阶段，最终使用，按国家和地区 - 工业分析，市场规模，市场份额，市场份额和预测从2023-2030开始

Biomarker Discovery Outsourcing Services Market, By Type, By Therapeutic Area, By Discovery Phase, By End Use, By Country, and By Region -Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年，生物标记发现外包服务市场规模为 112.1 亿美元，2023 年至 2030 年复合CAGR为 23.5%。

生物标记发现外包服务市场是更广泛的製药和生物技术领域中不断增长的领域。生物标记是分子或生物过程的量化指标，在疾病诊断、个人化医疗和药物开发等领域有广泛的应用。生物标记发现外包服务提供专业知识和资源，帮助学术研究机构、製药公司和其他组织验证、利用和识别用于多种目的的生物标记。

生物标记发现外包服务市场-市场动态

慢性病盛行率上升推动市场成长

癌症、心血管疾病、神经退化性疾病和糖尿病等慢性疾病盛行率的增加是市场扩张的主要因素。此外，伴随诊断的成长、对用于癌症检测的液体活检的关注，以及使用机器学习和人工智慧进行资料分析，这些新兴趋势都刺激了市场的需求。此外，随着个人化医疗变得更加普遍，以及对标靶治疗和诊断工具的需求增加，因此，对生物标记发现外包服务市场的需求预计将继续增长。此外，生物标记的发现是医疗保健和生命科学研究的重要组成部分。它有助于开发标靶疗法、了解疾病机制以及疾病的早期检测。这也导致对外包服务的需求不断增长，以加快生物标记研究。

生物标誌物发现外包服务市场 - 关键见解

  • 根据我们的研究分析师分享的分析，全球生物标记发现外包服务市场预计在预测期内（2023-2030 年）每年将以 23.5% 左右的CAGR增长
  • 由于对个人化医疗的需求不断增长，生物标记发现外包服务产业预计将以显着的速度成长
  • 根据类型细分，预计替代端点将在 2022 年显示最大的市场份额
  • 根据最终用途细分，生技公司是 2022 年的主导类型
  • 按地区划分，北美是 2022 年的主要收入来源。

生物标记发现外包服务市场-細項分析：

全球生物标记发现外包服务市场根据类型、治疗领域、发现阶段、最终用途和区域进行细分。

市场依类型分为四类：替代终点、预测生物标记、安全生物标记、预后生物标记等。替代端点部分的成长率最高。为了实现疾病进展或患者存活等关键目标，临床试验可能需要数年时间并需要大量资源。替代生物标记可以实现更有效率、更短的临床试验，因为它们可以提供治疗效果的早期迹象，预计这些优势将推动该领域的成长

根据最终用途，市场分为两类：生技公司、製药公司和其他。生技公司部门可能会在预测期内保持其主导地位。外包使生物技术公司能够利用合约研究组织 (CRO) 等专业服务提供者的专业知识。与维护内部团队、设备和基础设施相比，外包生物标记发现可能更具成本效益。生物技术公司可以透过专注于其核心竞争力（如治疗研究或药物开发）来更有效地分配资源。

生物标誌发现外包服务市场-地理洞察

透过区域分析，生物标记发现外包服务市场可分为北美、亚太地区、欧洲和世界其他地区。由于拥有创新技术、强大的生物技术产业、监管专业知识和先进的医疗基础设施，北美可能会主导市场。在该地区，美国食品药物管理局 (FDA) 和加拿大食品检验局 (CFIA) 等监管机构拥有着名的先进药物和诊断生物标记监管基础设施。这种监管清晰度支持验证工作和生物标记研究。此外，预计亚太地区在预测期内将出现最大增长。在该地区，中国和印度等多个经济体被视为生物技术和製药的新兴市场。对这些国家来说，外包生物标记发现计画的成本效益对全球製药公司具有吸引力。

生物标誌发现外包服务市场-竞争格局：

该领域的企业通常提供从样本采集到资料分析的广泛服务，以满足生物技术製药客户的多样化需求。各种专业生物技术公司和合约研究组织 (CRO) 提供生物标记发现服务。这些公司拥有代表客户进行生物标记相关研究和开发的基础设施和专业知识。该市场受到蛋白质组学和基因组学技术进步的影响，这使得更全面的生物标记发现成为可能。该领域的市场参与者正在采取多项策略性倡议，例如合作、伙伴关係和新产品发布，以维持其在市场上的业务立足点。

最近的发展：

2022 年1 月，Inotiv, Inc. 和Synexa Life Sciences 宣布，他们打算开展合作，加速Inotiv 生物标誌物的开发，这些生物标誌物对了解新型生物治疗药物的功效和安全性至关重要，并改善业务临床前发现和安全性评估服务。

目录

第 1 章：生物标记发现外包服务市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的生物标记发现外包服务市场片段
    • 按治疗领域分類的生物标记发现外包服务市场片段
    • 按发现阶段分類的生物标记发现外包服务市场片段
    • 生物标誌物发现外包服务市场片段（按最终用途）
    • 按国家/地区分類的生物标誌物发现外包服务市场摘要
    • 按地区分類的生物标记发现外包服务市场片段
  • 竞争洞察

第 3 章：生物标记发现外包服务主要市场趋势

  • 生物标誌物发现外包服务市场驱动因素
    • 市场驱动因素的影响分析
  • 生物标记发现外包服务市场限制
    • 市场限制影响分析
  • 生物标记发现外包服务市场机会
  • 生物标誌物发现外包服务市场未来趋势

第 4 章：生物标记发现外包服务产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：生物标记发现外包服务市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：生物标记发现外包服务市场格局

  • 2022 年生物标记发现外包服务市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：生物标誌物发现外包服务市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 替代终点
    • 预测性生物标记
    • 安全生物标记
    • 预后生物标记
    • 其他的

第 8 章：生物标记发现外包服务市场 - 按治疗领域

  • 概述
    • 按治疗领域分類的细分市场占有率分析
    • 自体免疫疾病
    • 肿瘤学
    • 心臟病学
    • 神经病学
    • 其他的

第 9 章：生物标记发现外包服务市场 - 按发现阶段

  • 概述
    • 按发现阶段分類的细分市占率分析
    • 生物标誌物选择
    • 生物标记鑑定
    • 生物标记验证
    • 生物标记物组合开发
    • 生物标记分析

第 10 章：生物标记发现外包服务市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 生技公司
    • 製药公司
    • 其他的

第 11 章：生物标记发现外包服务市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 生物标誌物发现外包服务北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模与预测（按治疗领域）
    • 北美市场规模和预测（按发现阶段）
    • 北美市场规模和预测（按最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 生物标誌物发现外包服务欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模与预测（按治疗领域）
    • 欧洲市场规模和预测（按发现阶段）
    • 欧洲市场规模和预测（按最终用途）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 生物标誌物发现外包服务亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 按治疗领域分類的亚太市场规模和预测
    • 按发现阶段分類的亚太市场规模和预测
    • 亚太地区市场规模和预测（按最终用途）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 生物标誌物发现外包服务拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按治疗领域）
    • 拉丁美洲市场规模和预测（按发现阶段）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 生物标誌物发现外包服务中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按治疗领域）
    • 中东和非洲市场规模和预测（按发现阶段）
    • 中东和非洲市场规模和预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 生物标记发现外包服务产业

  • 竞争仪表板
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Laboratory Corporation of America Holdings
    • GHO Capital
    • ICON plc
    • Agilent
    • Proteome Sciences
    • Charles River Laboratories.
    • Eurofins Scientific
    • Celerion
    • Evotec
    • Parexel International (MA) Corporation

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1840

REPORT HIGHLIGHT

Biomarker discovery outsourcing services market size was valued at USD 11,210 Million in 2022, expanding at a CAGR of 23.5% from 2023 to 2030.

The biomarker discovery outsourcing services market is a growing sector within the broader pharmaceutical and biotechnology sector. Biomarkers are quantifiable indicators of molecular or biological processes with a wide range of applications in areas including disease diagnosis, personalized medicine, and drug development. Biomarker discovery outsourcing services provide specialized expertise and resources to help academic research institutions, pharmaceutical companies, and other organizations validate, utilize, and identify biomarkers for several purposes.

Biomarker Discovery Outsourcing Services Market- Market Dynamics

The rising prevalence of chronic diseases is propelling market growth

The increase in the prevalence of chronic diseases including cancer, cardiovascular diseases, neurodegenerative conditions, and diabetes are major contributing factors to the market expansion. Additionally, the growth of companion diagnostics, a focus on liquid biopsy for cancer detection, and the use of machine learning and artificial intelligence for data analysis are emerging trends fueling the demand of the market. Moreover, as personalized medicine becomes more prevalent and as the demand for targeted therapies and diagnostic tools increases, thus, the demand for biomarker discovery outsourcing services market is expected to continue growing. Furthermore, biomarker discovery is a crucial component of healthcare and life sciences research. It aids in developing targeted therapies, understanding disease mechanisms, and the early detection of diseases. This also led to a rising demand for outsourcing services to expedite biomarker research.

Biomarker Discovery Outsourcing Services Market- Key Insights

  • As per the analysis shared by our research analyst, the global biomarker discovery outsourcing services market is estimated to grow annually at a CAGR of around 23.5% over the forecast period (2023-2030)
  • The biomarker discovery outsourcing services industry is projected to grow at a significant rate due to the growing demand for personalized medicine
  • Based on type segmentation, surrogate endpoints was predicted to show maximum market share in the year 2022
  • Based on end use segmentation, biotechnology companies was the leading type in 2022
  • Based on Region, North America was the leading revenue generator in 2022.

Biomarker Discovery Outsourcing Services Market- Segmentation Analysis:

The global biomarker discovery outsourcing services market is segmented on the basis of type, therapeutic area, discovery phase, end use, and region.

The market is divided into four categories based on type: surrogate endpoints, predictive biomarkers, safety biomarkers, prognostic biomarkers, and others. The surrogate endpoints segment is accounted to witness the highest growth rate. To accomplish crucial objectives such as disease progression or patient survival, clinical trials can take years and need substantial resources. Surrogate biomarkers enables for more efficient and shorter clinical trials because they can offer early indications of treatment efficacy, such advantages are projected to drive the segment's growth

The market is divided into two categories based on end use: biotechnology companies, pharmaceutical companies, and others. The biotechnology companies segment is likely to maintain its dominance over the forecast period. Outsourcing enables biotechnology companies to tap into the expertise of specialized service providers, such as Contract Research Organizations (CROs). Outsourcing biomarker discovery might be cost-effective over maintaining in-house teams, equipment, and infrastructure. Biotechnology companies can allocate resources more effectively by focusing on their core competencies, like therapeutic research or drug development.

Biomarker Discovery Outsourcing Services Market- Geographical Insights

By regional analysis, the biomarker discovery outsourcing services market can be segmented into North America, Asia Pacific, Europe, and the Rest of the World. North America is likely to dominate the market due to its access to innovating technologies, robust biotech industry, regulatory expertise, and advanced healthcare infrastructure. In the region, regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the Canadian Food Inspection Agency (CFIA), have renowned regulatory infrastructure for biomarkers in advanced drugs and diagnostics. This regulatory clarity supports validation efforts and biomarker research. Furthermore, Asia Pacific is anticipated to witness maximum growth during the forecast period. In the region, various economies such as China and India are considered emerging markets for biotechnology and pharmaceuticals. To these countries, the cost-effectiveness of outsourcing biomarker discovery projects can be attractive to worldwide pharmaceutical business.

Biomarker Discovery Outsourcing Services Market- Competitive Landscape:

Businesses in this space typically provide a vast range of services, from sample collection to data analysis, to meet the diverse needs of biotechnology pharmaceutical clients. Various specialized biotechnology companies and contract research organizations (CROs) offer biomarker discovery services. These companies have the infrastructure and expertise to carry out biomarker-related research and development on behalf of their clients. The market is influenced by the advancement of technology in proteomics and genomics which allow more comprehensive biomarker discovery. Market players operating in this sector are adopting several strategic initiatives, such as collaborations, partnerships, and new product launches, to maintain their business foothold in the market.

Recent Developments:

In January 2022, Inotiv, Inc. and Synexa Life Sciences announced that they intend to form a collaboration that will accelerate Inotiv's development of biomarkers important to the understanding of efficacy and safety of novel biotherapeutics, improve the business preclinical discovery and safety assessment services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET KEY PLAYERS

  • Thermo Fisher Scientific Inc.
  • Laboratory Corporation of America Holdings
  • GHO Capital
  • ICON plc
  • Agilent
  • Proteome Sciences
  • Charles River Laboratories.
  • Eurofins Scientific
  • Celerion
  • Evotec
  • Parexel International (MA) Corporation

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY TYPE

  • Surrogate endpoints
  • Predictive biomarkers
  • Safety biomarkers
  • Prognostic biomarkers
  • Others

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY THERAPEUTIC AREA

  • Autoimmune Diseases
  • Oncology
  • Cardiology
  • Neurology
  • Others

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY DISCOVERY PHASE

  • Biomarker Selection
  • Biomarker Identification
  • Biomarker Validation
  • Biomarker Panel Development
  • Biomarker Profiling

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY END USE

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Others

GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Biomarker Discovery Outsourcing Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biomarker Discovery Outsourcing Services Market Snippet by Type
    • 2.1.2. Biomarker Discovery Outsourcing Services Market Snippet by Therapeutic Area
    • 2.1.3. Biomarker Discovery Outsourcing Services Market Snippet by Discovery Phase
    • 2.1.4. Biomarker Discovery Outsourcing Services Market Snippet by End Use
    • 2.1.5. Biomarker Discovery Outsourcing Services Market Snippet by Country
    • 2.1.6. Biomarker Discovery Outsourcing Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Biomarker Discovery Outsourcing Services Key Market Trends

  • 3.1. Biomarker Discovery Outsourcing Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biomarker Discovery Outsourcing Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biomarker Discovery Outsourcing Services Market Opportunities
  • 3.4. Biomarker Discovery Outsourcing Services Market Future Trends

4. Biomarker Discovery Outsourcing Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biomarker Discovery Outsourcing Services Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biomarker Discovery Outsourcing Services Market Landscape

  • 6.1. Biomarker Discovery Outsourcing Services Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biomarker Discovery Outsourcing Services Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
    • 7.1.2. Surrogate endpoints
    • 7.1.3. Predictive biomarkers
    • 7.1.4. Safety biomarkers
    • 7.1.5. Prognostic biomarkers
    • 7.1.6. Others

8. Biomarker Discovery Outsourcing Services Market - By Therapeutic Area

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Area, 2022&2030 (%)
    • 8.1.2. Autoimmune Diseases
    • 8.1.3. Oncology
    • 8.1.4. Cardiology
    • 8.1.5. Neurology
    • 8.1.6. Others

9. Biomarker Discovery Outsourcing Services Market - By Discovery Phase

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Discovery Phase, 2022&2030 (%)
    • 9.1.2. Biomarker Selection
    • 9.1.3. Biomarker Identification
    • 9.1.4. Biomarker Validation
    • 9.1.5. Biomarker Panel Development
    • 9.1.6. Biomarker Profiling

10. Biomarker Discovery Outsourcing Services Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2022&2030 (%)
    • 10.1.2. Biotechnology Companies
    • 10.1.3. Pharmaceutical Companies
    • 10.1.4. Others

11. Biomarker Discovery Outsourcing Services Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Biomarker Discovery Outsourcing Services Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Biomarker Discovery Outsourcing Services Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific Inc.
    • 12.2.2. Laboratory Corporation of America Holdings
    • 12.2.3. GHO Capital
    • 12.2.4. ICON plc
    • 12.2.5. Agilent
    • 12.2.6. Proteome Sciences
    • 12.2.7. Charles River Laboratories.
    • 12.2.8. Eurofins Scientific
    • 12.2.9. Celerion
    • 12.2.10. Evotec
    • 12.2.11. Parexel International (MA) Corporation

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Biomarker Discovery Outsourcing Services Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by Type2018-2030 (USD Million)
  • TABLE Biomarker Discovery Outsourcing Services Market: Therapeutic AreaSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Area
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area2018-2030 (USD Million)
  • TABLE Biomarker Discovery Outsourcing Services Market: Discovery Phase Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Discovery Phase
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase 2018-2030 (USD Million)
  • TABLE Biomarker Discovery Outsourcing Services Market: End Use Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End Use
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by End Use 2018-2030 (USD Million)
  • TABLE Biomarker Discovery Outsourcing Services Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Biomarker Discovery Outsourcing Services Market, by Region 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE North America Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
  • TABLE Europe Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE EuropeBiomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE EuropeBiomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE EuropeBiomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE Latin America Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)